Skip to content

Haemonetics HAE Total debt

Total debt at other companies

TFX
TeleflexTFX
$2.78B+38.6%
LivaNova logo
LivaNovaLIVN
$340.94M-49.7%
ICU Medical logo
ICU MedicalICUI
$1.36B-17.5%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$821.56M+0.5%
Abbott logo
AbbottABT
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.37B-18.0%
Enterprise value$4.4B-12.5%
P/S2.5×-0.5×

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Calculated from Haemonetics’s reported figures.

Plus components not separately reported this period.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's total debt?
Haemonetics (HAE) reported total debt of $1.27B in Q1 2026.
How has Haemonetics's total debt changed year-over-year?
Haemonetics's total debt decreased by 0.7% year-over-year, from $1.28B to $1.27B.
What is the long-term trend for Haemonetics's total debt?
Over 5 years (2021 to 2026), Haemonetics's total debt has grown at a 10.4% compound annual growth rate (CAGR), from $778.28M to $1.27B.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.